K
Keina Susana-Quiroz
Publications - 1
Citations - 169
Keina Susana-Quiroz is an academic researcher. The author has contributed to research in topics: Cancer & Hazard ratio. The author has an hindex of 1, co-authored 1 publications receiving 58 citations.
Papers
More filters
Journal ArticleDOI
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
J. Garcia-Suarez,Javier de la Cruz,Ángel Cedillo,Pilar Llamas,Rafael F. Duarte,Víctor Jiménez-Yuste,Jose Angel Hernandez-Rivas,Rodrigo Gil-Manso,Mi Kwon,Mi Kwon,Pedro Sánchez-Godoy,Pilar Martínez-Barranco,Blanca Colás-Lahuerta,Pilar Herrera,Laurentino Benito-Parra,Adrian Alegre,Alberto Velasco,Arturo Matilla,María Concepción Aláez-Usón,Rafael Martos-Martínez,Carmen Martínez-Chamorro,Keina Susana-Quiroz,Juan F del Campo,Adolfo de la Fuente,Regina Herráez,Adriana Pascual,E. Gómez,Jaime Pérez-Oteyza,Elena Ruiz,Arancha Alonso,José González-Medina,Lucía Núñez Martín-Buitrago,Miguel Canales,Isabel González-Gascón,María Carmen Vicente-Ayuso,Susana Valenciano,María García Roa,Pablo Estival Monteliu,Javier López-Jiménez,Cristian Escolano Escobar,Javier Ortiz-Martín,José Luis Díez-Martín,José Luis Díez-Martín,Joaquin Martinez-Lopez +43 more
TL;DR: Mortality was associated with higher age, more comorbidities, type of hematological malignancy and type of antineoplastic therapy, and further studies and long-term follow-up are required to validate these criteria for risk stratification.